Literature DB >> 20535029

A comparison of the psychometric properties of 4 postconcussion syndrome measures in a nonclinical sample.

Karen Sullivan1, Natalie Garden.   

Abstract

OBJECTIVE: To investigate the psychometric properties of 4 established postconcussive symptoms (PCS) measures. PARTICIPANTS: Ninety-six nonclinical participants (49 university students and 47 nonstudents; 73% male). Nonclinical participants were recruited because PCS symptoms are common in both clinical and nonclinical groups. MAIN OUTCOME MEASURES: Rivermead Postconcussion Symptoms Questionnaire, the Postconcussion Syndrome Symptom Scale, the Postconcussion Syndrome Checklist, and the British Columbia Postconcussion Symptom Inventory were completed in a counterbalanced order. ANALYSIS: Internal consistency and split-half reliability coefficients were calculated for each PCS measure. Convergent validity was examined using intercorrelations between PCS measures. Divergent validity was examined using correlations between each of the PCS measures and depression.
RESULTS: PCS measures had moderate to good reliability and were significantly and positively correlated with each other. Divergent validity correlations were generally weaker than those between PCS measures.
CONCLUSION: This study is the first to examine the psychometric properties of multiple PCS measures in a single sample. Given that clinicians may not know in advance the clinical or nonclinical group status of their clients, particularly in mild trauma cases, our data may help researchers and clinicians compare and select PCS measures.

Entities:  

Mesh:

Year:  2011        PMID: 20535029     DOI: 10.1097/HTR.0b013e3181e47f95

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  7 in total

1.  Comparison of SNOMED CT versus Medcin terminology concept coverage for mild Traumatic Brain Injury.

Authors:  Diane Montella; Steven H Brown; Peter L Elkin; James C Jackson; S Trent Rosenbloom; Dietlind Wahner-Roedler; Gail Welsh; Bryan Cotton; Oscar D Guillamondegui; Henry Lew; Katherine H Taber; Larry A Tupler; Rodney Vanderploeg; Theodore Speroff
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Measuring executive function in control subjects and TBI patients with question completion time (QCT).

Authors:  David L Woods; E William Yund; John M Wyma; Ron Ruff; Timothy J Herron
Journal:  Front Hum Neurosci       Date:  2015-05-19       Impact factor: 3.169

3.  Cognitive behavioural treatment for the chronic post-traumatic headache patient: a randomized controlled trial.

Authors:  Dorte Kjeldgaard; Hysse B Forchhammer; Thomas W Teasdale; Rigmor H Jensen
Journal:  J Headache Pain       Date:  2014-12-02       Impact factor: 7.277

4.  Workplace and non-workplace mild traumatic brain injuries in an outpatient clinic sample: A case-control study.

Authors:  Douglas P Terry; Grant L Iverson; William Panenka; Angela Colantonio; Noah D Silverberg
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

5.  The influence of self-reported history of mild traumatic brain injury on cognitive performance.

Authors:  Amaya J Fox; Hannah L Filmer; Paul E Dux
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

6.  Is the Rivermead Post-Concussion Symptoms Questionnaire a Reliable and Valid Measure to Assess Long-Term Symptoms in Traumatic Brain Injury and Orthopedic Injury Patients? A Novel Investigation Using Rasch Analysis.

Authors:  Shivanthi Balalla; Chris Krägeloh; Oleg Medvedev; Richard Siegert
Journal:  Neurotrauma Rep       Date:  2020-08-11

7.  Methodology and Implementation of a Randomized Controlled Trial (RCT) for Early Post-concussion Rehabilitation: The Active Rehab Study.

Authors:  Johna K Register-Mihalik; Kevin M Guskiewicz; Stephen W Marshall; Karen L McCulloch; Jason P Mihalik; Martin Mrazik; Ian Murphy; Dhiren Naidu; Shabbar I Ranapurwala; Kathryn Schneider; Paula Gildner; Michael McCrea
Journal:  Front Neurol       Date:  2019-11-08       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.